Literature DB >> 35020165

Hydrocephalus and myasthenia gravis: neurological manifestations in autoimmune polyendocrine syndrome type II.

Germán Morís1, Dolores Colunga2.   

Abstract

Entities:  

Keywords:  Autoimmune; Autoimmune polyendocrine syndromes; Hydrocephalus; Myasthenia gravis

Year:  2022        PMID： 35020165     DOI： 10.1007/s13760-022-01867-7

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  4 in total

1.  [Studies on renal hypertension. 3. Study on the reliability of differential renal function test in clinical cases].

Authors:  T Ikeda
Journal:  Sapporo Igaku Zasshi       Date:  1966 May-Jun

2.  Management of hydrocephalus associated with autoimmune diseases: a series of 19 cases.

Authors:  Baitao Ma; Hao Wu; Hexiang Yin; Jianbo Chang; Li Wang; Renzhi Wang; Wenbin Ma; Yongning Li; Jian Guan; Jinjing Liu; Junji Wei
Journal:  Autoimmunity       Date:  2017-07-07       Impact factor: 2.815

Review 3.  Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets.

Authors:  Jason K Karimy; Benjamin C Reeves; Eyiyemisi Damisah; Phan Q Duy; Prince Antwi; Wyatt David; Kevin Wang; Steven J Schiff; David D Limbrick; Seth L Alper; Benjamin C Warf; Maiken Nedergaard; J Marc Simard; Kristopher T Kahle
Journal:  Nat Rev Neurol       Date:  2020-03-09       Impact factor: 42.937

4.  Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report.

Authors:  Hidefumi Inaba; Hiroyuki Ariyasu; Hiroshi Iwakura; Chiaki Kurimoto; Yoko Ueda; Shinsuke Uraki; Ken Takeshima; Yasushi Furukawa; Shuhei Morita; Yoshiaki Nakayama; Takuya Ohashi; Hidefumi Ito; Yoshiharu Nishimura; Takashi Akamizu
Journal:  BMC Endocr Disord       Date:  2020-04-07       Impact factor: 2.763
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.